In vivo analysis of thrombus formation in arthritic mice

References

• McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet (London, England). 2017;389(10086):2328–37.
   PubMed Web of Science ®Google Scholar
• Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107(9):1303–7.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Freundlich B, Straus WL. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol. 2003;30(1):36–40.
   PubMed Web of Science ®Google Scholar
• Levy L, Fautrel B, Barnetche T, Schaeverbeke T. Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. Clin Exp Rheumatol. 2008;26(4):673–9.
   PubMed Web of Science ®Google Scholar
• Arida A, Protogerou AD, Kitas GD, Sfikakis PP. Systemic inflammatory response and atherosclerosis: the paradigm of chronic inflammatory rheumatic diseases. Ijms. 2018;7:19.
   Google Scholar
• Roman MJ, Moeller E, Davis A, Paget SA, Crow MK, Lockshin MD, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med. 2006;144(4):249–56.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Pineiro A, Garcia-Porrua C, Miranda-Filloy JA, et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum. 2007;57(1):125–32.
   PubMedGoogle Scholar
• van den Oever IA, Sattar N, Nurmohamed MT. Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic system. Ann Rheum Dis. 2014;73(6):954–7.
   PubMed Web of Science ®Google Scholar
• Zhang H, Park Y, Wu J, Chen X, Lee S, Yang J, et al. Role of TNF-alpha in vascular dysfunction. Clin Sci (London, England: 1979). 2009;116(3):219–30.
   PubMed Web of Science ®Google Scholar
• Chen X, Andresen BT, Hill M, Zhang J, Booth F, Zhang C. Role of reactive oxygen species in tumor necrosis factor-alpha induced endothelial dysfunction. Chyr. 2008;4(4):245–55.
   Google Scholar
• Komai N, Morita Y, Sakuta T, Kuwabara A, Kashihara N. Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis. Mod Rheumatol.2007;17(5):385–90.
   PubMedGoogle Scholar
• Ingegnoli F, Fantini F, Favalli EG, Soldi A, Griffini S, Galbiati V, et al. Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade. J Autoimmunity. 2008;31(2):175–9.
   PubMed Web of Science ®Google Scholar
• Dixon WG, Watson KD, Lunt M, Hyrich KL, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register Control Centre Consortium. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum. 2007;56(9):2905–12.
   PubMed Web of Science ®Google Scholar
• Nishimura S, Manabe I, Nagasaki M, Kakuta S, Iwakura Y, Takayama N, et al. In vivo imaging visualizes discoid platelet aggregations without endothelium disruption and implicates contribution of inflammatory cytokine and integrin signaling. Blood. 2012;119(8):e45–56.
   PubMed Web of Science ®Google Scholar
• Hayward MD, Jones BK, Saparov A, Hain HS, Trillat AC, Bunzel MM, et al. An extensive phenotypic characterization of the hTNFalpha transgenic mice. BMC Physiol. 2007;7(1):13.
   PubMedGoogle Scholar
• Mukai T, Gallant R, Ishida S, Kittaka M, Yoshitaka T, Fox DA, et al. Loss of SH3 domain-binding protein 2 function suppresses bone destruction in tumor necrosis factor-driven and collagen-induced arthritis in mice. Arthritis Rheumatol (Hoboken, NJ). 2015;67(3):656–67.
   PubMed Web of Science ®Google Scholar
• Mukai T, Ishida S, Ishikawa R, Yoshitaka T, Kittaka M, Gallant R, et al. SH3BP2 cherubism mutation potentiates TNF-alpha-induced osteoclastogenesis via NFATc1 and TNF-alpha-mediated inflammatory bone loss. J Bone Miner Res. 2014;29(12):2618–35.
   PubMed Web of Science ®Google Scholar
• Kikuta J, Wada Y, Kowada T, Wang Z, Sun-Wada GH, Nishiyama I, et al. Dynamic visualization of RANKL and Th17-mediated osteoclast function. J Clin Invest. 2013;123(2):866–73.
   PubMed Web of Science ®Google Scholar
• Furuya M, Kikuta J, Fujimori S, Seno S, Maeda H, Shirazaki M, et al. Direct cell–cell contact between mature osteoblasts and osteoclasts dynamically controls their functions in vivo. Nat Commun. 2018;9(1):300.
   PubMedGoogle Scholar
• Bernardo A, Ball C, Nolasco L, Moake JF, Dong JF. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood. 2004;104(1):100–6.
   PubMed Web of Science ®Google Scholar
• Pircher J, Merkle M, Wornle M, Ribeiro A, Czermak T, Stampnik Y, et al. Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor subtype 2. Arthritis Res Ther. 2012;14(5):R225.
   PubMed Web of Science ®Google Scholar
• Pignatelli P, De Biase L, Lenti L, Tocci G, Brunelli A, Cangemi R, et al. Tumor necrosis factor-alpha as trigger of platelet activation in patients with heart failure. Blood. 2005;106(6):1992–4.
   PubMed Web of Science ®Google Scholar
• Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Atvb. 2003;23(12):2131–7.
   Google Scholar
• Khan MM, Liu Y, Khan ME, Gilman ML, Khan ST, Bromberg M, et al. Upregulation of tissue factor in monocytes by cleaved high molecular weight kininogen is dependent on TNF-alpha and IL-1beta. Am J Physiol Heart Circ Physiol. 2010;298(2):H652–8.
   PubMed Web of Science ®Google Scholar
• Bond AR, Jackson CL. The fat-fed apolipoprotein E knockout mouse brachiocephalic artery in the study of atherosclerotic plaque rupture. J Biomed Biotechnol. 2011;2011:379069.
   PubMedGoogle Scholar
• Matoba T, Sato K, Egashira K. Mouse models of plaque rupture. Curr Opin Lipidol. 2013;24(5):419–25.
   PubMed Web of Science ®Google Scholar
• Rauova L. “Radical” model of thrombosis. Blood. 2012;119(8):1798–9.
   PubMed Web of Science ®Google Scholar
• Li W, McIntyre TM, Silverstein RL. Ferric chloride-induced murine carotid arterial injury: a model of redox pathology. Redox Biol. 2013;1(1):50–5.
   PubMed Web of Science ®Google Scholar
• Furie B, Furie BC. In vivo thrombus formation. J Thromb Haemost. 2007;5(Suppl 1):12–7.
   PubMedGoogle Scholar
• Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res.1990;60(4):269–80.
   PubMed Web of Science ®Google Scholar